Brought to you by 
Esprit Pharma brings in $5.14mm with its Series A round
30 Jun 2005
Executive Summary
Esprit Pharma (specialty pharmaceuticals) has brought in $5.14mm with its Series A venture round. Apax Partners, Domain Associates, and New Enterprise Associates co-led the financing.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Esprit Pharma brings in $5.14mm with its Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice